Cite
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
MLA
Jordan, Stanley C., et al. “A Phase I/II, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol. 18, no. 12, Dec. 2018, pp. 2955–64. EBSCOhost, https://doi.org/10.1111/ajt.14767.
APA
Jordan, S. C., Choi, J., Aubert, O., Haas, M., Loupy, A., Huang, E., Peng, A., Kim, I., Louie, S., Ammerman, N., Najjar, R., Puliyanda, D., & Vo, A. (2018). A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 18(12), 2955–2964. https://doi.org/10.1111/ajt.14767
Chicago
Jordan, Stanley C, Jua Choi, Olivier Aubert, Mark Haas, Alexandre Loupy, Edmund Huang, Alice Peng, et al. 2018. “A Phase I/II, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 18 (12): 2955–64. doi:10.1111/ajt.14767.